Interventional agents safety and pharmacokinetic services

Active Awarded Last action

Contract number
75N93026F00001
Awardee
Awarding agency
Obligated
$627,922

Award facts

Contract value 57% obligated
$1,095,062.00 Current and potential, with all options
Completion date 66% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
St Charles, MO, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $148,400

About this award

The National Institute of Allergy and Infectious Diseases issued a $1,095,062 delivery order to Eurofins Discovery Services North America, LLC on February 25, 2026, for interventional agents safety and pharmacokinetic services, under the Nonclinical Services for Development of Interventional Agents parent master IDIQ vehicle.

Place of performance is St. Charles, Missouri. The order carries a firm fixed price structure and ultimate completion date of February 24, 2027. No set-aside was used.

Quick answers

Who was awarded contract 75N93026F00001?

75N93026F00001 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 25, 2026.

How much is contract 75N93026F00001 worth?

The government has obligated $627,922 on 75N93026F00001. Its current value, with exercised options, is $1,095,062.

Is contract 75N93026F00001 an order under another contract?

Yes. 75N93026F00001 is a delivery order under 75N93025D00011, an indefinite delivery contract.

Was contract 75N93026F00001 competed?

The extent of competition for 75N93026F00001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award